toxylact: a06AB02 Bisacodyl

The first professional lActological database in the word

Here is a ready-to-use English web-page monograph for ATC A06AB02, written in a concise toxicological-lactological style and aligned with the open Framar page on bisacodyl, which identifies it as a contact stimulant laxative used for constipation, bowel preparation, and related indications, with detailed safety, pregnancy, and breastfeeding notes.medpedia.framar

A06AB02: Bisacodyl and Related Stimulant Laxatives

ATC code A06AB02 covers bisacodyl, a contact stimulant laxative used to relieve episodic and chronic constipation and to prepare the bowel before diagnostic or surgical procedures.medpedia.framar
It acts primarily on the colon, promoting peristalsis and increasing water and electrolyte secretion into the bowel lumen, with onset typically within 6 to 12 hours after oral use and 15 to 60 minutes after rectal use.medpedia.framar

Toxicological profile

Bisacodyl is generally well tolerated when used short term, but excessive or prolonged use may cause diarrhea, abdominal cramping, dehydration, and electrolyte imbalance, especially hypokalemia.medpedia.framar
Overdose or misuse may lead to more severe fluid and electrolyte disturbances, including weakness, vomiting, and metabolic derangement.medpedia.framar
Rectal formulations may also cause local irritation, burning, or proctitis, particularly in patients with anorectal inflammation or fissures.medpedia.framar

Lactation profile

Available clinical data indicate that bisacodyl and its active metabolite are not excreted into breast milk in clinically relevant amounts.medpedia.framar
For that reason, use during breastfeeding is usually considered compatible when there is a clear clinical need, although the drug should still be used cautiously and for the shortest effective duration.medpedia.framar
Because stimulant laxatives are intended for intermittent rather than chronic use, repeated self-medication during lactation should be avoided without medical supervision.medpedia.framar

Pregnancy considerations

Controlled pregnancy data are limited, so bisacodyl should be used in pregnancy only when clearly needed and after weighing maternal benefit against potential fetal risk.medpedia.framar
The available source does not report a specific teratogenic signal, but routine or prolonged use is not recommended.medpedia.framar
When constipation requires treatment in pregnancy, short-term use under professional guidance is the preferred approach.medpedia.framar

Clinical precautions

Bisacodyl is contraindicated in suspected intestinal obstruction, ileus, perforation, acute surgical abdomen, toxic megacolon, severe dehydration, and significant electrolyte disturbances.medpedia.framar
It should not be used continuously for long periods without evaluating the cause of constipation, because chronic use may worsen fluid loss and promote laxative dependence.medpedia.framar
Concomitant use with diuretics, corticosteroids, antacids, H2 blockers, or digoxin may be clinically relevant because of interactions or additive electrolyte effects.medpedia.framar

Summary

A06AB02 is a classic stimulant laxative class represented by bisacodyl, with reliable short-term efficacy, predictable onset, and important safety limits in toxicity-prone settings.medpedia.framar
For lactological use, the available evidence supports low transfer into milk, making it a practical option when intermittent laxative therapy is required during breastfeeding.medpedia.framar

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.